430 related articles for article (PubMed ID: 17530260)
21. Epidemiology and etiology of bladder cancer.
Johansson SL; Cohen SM
Semin Surg Oncol; 1997; 13(5):291-8. PubMed ID: 9259084
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology of bladder cancer.
Malats N; Real FX
Hematol Oncol Clin North Am; 2015 Apr; 29(2):177-89, vii. PubMed ID: 25836927
[TBL] [Abstract][Full Text] [Related]
23. Environmental factors promoting bladder cancer.
Hirao Y; Kim WJ; Fujimoto K
Curr Opin Urol; 2009 Sep; 19(5):494-9. PubMed ID: 19553820
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018.
Cumberbatch MGK; Jubber I; Black PC; Esperto F; Figueroa JD; Kamat AM; Kiemeney L; Lotan Y; Pang K; Silverman DT; Znaor A; Catto JWF
Eur Urol; 2018 Dec; 74(6):784-795. PubMed ID: 30268659
[TBL] [Abstract][Full Text] [Related]
25. Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population.
Rouissi K; Ouerhani S; Marrakchi R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; El Gaaied AB
Cancer Genet Cytogenet; 2009 Apr; 190(2):101-7. PubMed ID: 19380028
[TBL] [Abstract][Full Text] [Related]
26. Smoking and polymorphisms in xenobiotic metabolism and DNA repair genes are additive risk factors affecting bladder cancer in Northern Tunisia.
Rouissi K; Ouerhani S; Hamrita B; Bougatef K; Marrakchi R; Cherif M; Ben Slama MR; Bouzouita M; Chebil M; Ben Ammar Elgaaied A
Pathol Oncol Res; 2011 Dec; 17(4):879-86. PubMed ID: 21647780
[TBL] [Abstract][Full Text] [Related]
27. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
28. [Epidemiology of disease conditions in Italy. Has anything changed? Environment, professional exposure, and lifestyle. Is time for screening?].
Serretta V; Colombo R
Urologia; 2013; 80 Suppl 21():3-6. PubMed ID: 23559128
[TBL] [Abstract][Full Text] [Related]
29. A case-control study on the etiology of urinary bladder cancer in Istanbul, Turkey.
Yaris F; Dikici MF; Sabuncu HH; Yaris E
Asian Pac J Cancer Prev; 2006; 7(4):591-4. PubMed ID: 17250433
[TBL] [Abstract][Full Text] [Related]
30. Occupational exposures and genetic susceptibility to urinary tract cancers: a systematic review and meta-analysis.
Stojanovic J; Milovanovic S; Pastorino R; Iavicoli I; Boccia S
Eur J Cancer Prev; 2018 Sep; 27(5):468-476. PubMed ID: 28403014
[TBL] [Abstract][Full Text] [Related]
31. Smoking status, usual adult occupation, and risk of recurrent urothelial bladder carcinoma: data from The Cancer Genome Atlas (TCGA) Project.
Wilcox AN; Silverman DT; Friesen MC; Locke SJ; Russ DE; Hyun N; Colt JS; Figueroa JD; Rothman N; Moore LE; Koutros S
Cancer Causes Control; 2016 Dec; 27(12):1429-1435. PubMed ID: 27804056
[TBL] [Abstract][Full Text] [Related]
32. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender.
Samanic C; Kogevinas M; Dosemeci M; Malats N; Real FX; Garcia-Closas M; Serra C; Carrato A; García-Closas R; Sala M; Lloreta J; Tardón A; Rothman N; Silverman DT
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1348-54. PubMed ID: 16835335
[TBL] [Abstract][Full Text] [Related]
33. Phase II Drug-Metabolizing Polymorphisms and Smoking Predict Recurrence of Non-Muscle-Invasive Bladder Cancer: A Gene-Smoking Interaction.
Lacombe L; Fradet V; Lévesque É; Pouliot F; Larue H; Bergeron A; Hovington H; Caron A; Nguile-Makao M; Harvey M; Fradet Y; Guillemette C
Cancer Prev Res (Phila); 2016 Feb; 9(2):189-95. PubMed ID: 26645279
[TBL] [Abstract][Full Text] [Related]
34. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
35. Are the apparent effects of cigarette smoking on lung and bladder cancers due to uncontrolled confounding by occupational exposures?
Siemiatycki J; Dewar R; Krewski D; Désy M; Richardson L; Franco E
Epidemiology; 1994 Jan; 5(1):57-65. PubMed ID: 8117783
[TBL] [Abstract][Full Text] [Related]
36. A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke.
Alberg AJ; Kouzis A; Genkinger JM; Gallicchio L; Burke AE; Hoffman SC; Diener-West M; Helzlsouer KJ; Comstock GW
Am J Epidemiol; 2007 Mar; 165(6):660-6. PubMed ID: 17204516
[TBL] [Abstract][Full Text] [Related]
37. Unexplained excess risk of bladder cancer in men.
Hartge P; Harvey EB; Linehan WM; Silverman DT; Sullivan JW; Hoover RN; Fraumeni JF
J Natl Cancer Inst; 1990 Oct; 82(20):1636-40. PubMed ID: 2213906
[TBL] [Abstract][Full Text] [Related]
38. Combined effect of NAT2, MTR and MTHFR genotypes and tobacco on bladder cancer susceptibility in Tunisian population.
Ouerhani S; Rouissi K; Marrakchi R; Ben Slama MR; Sfaxi M; Chebil M; ElGaaied AB
Cancer Detect Prev; 2009; 32(5-6):395-402. PubMed ID: 19588544
[TBL] [Abstract][Full Text] [Related]
39. Life style and occupational risk factors for bladder cancer in Germany. A case-control study.
Kunze E; Chang-Claude J; Frentzel-Beyme R
Cancer; 1992 Apr; 69(7):1776-90. PubMed ID: 1551063
[TBL] [Abstract][Full Text] [Related]
40. Nonsmoking-related arylamine exposure and bladder cancer risk.
Skipper PL; Tannenbaum SR; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):503-7. PubMed ID: 12814994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
